Brands: Minivelle · Estradiol
Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Noven Therapeutics, LLC | unknown | 10 | SUPPLYING |
| A-S Medication Solutions | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin. — Recalling firm: Noven Pharmaceuticals Inc — Nationwide within the United States
Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin. — Recalling firm: Noven Pharmaceuticals Inc — Nationwide within the United States
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide
Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide
Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide in the USA.
Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide in the USA.
Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide within US
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions. — Recalling firm: Noven Pharmaceuticals, Inc. — Nationwide
